NGM Bio Reports Topline Results from 24-Week Phase 2b ALPINE 2/3 Study of Aldafermin in NASH Portfolio News / By Karina Tin May 24, 2021 NGM Bio Reports Topline Results from 24-Week Phase 2b ALPINE 2/3 Study of Aldafermin in NASH Read More »
Tenaya Therapeutics Receives Orphan Drug Designation and Presents Pre-Clinical Data for its Most Advanced Gene Therapy Product Candidate for Genetic Hypertrophic Cardiomyopathy Portfolio News / By Karina Tin May 20, 2021 Tenaya Therapeutics Receives Orphan Drug Designation and Presents Pre-Clinical Data for its Most Advanced Gene Therapy Product Candidate for Genetic Hypertrophic Cardiomyopathy Read More »
Escient Pharmaceuticals Appoints Christian Weyer, M.D., M.A.S., As President And Chief Medical Officer Portfolio News / By Karina Tin May 17, 2021 Escient Pharmaceuticals Appoints Christian Weyer, M.D., M.A.S., As President And Chief Medical Officer Read More »
RAPT Therapeutics Reports First Quarter 2021 Financial Results Portfolio News / By Karina Tin May 11, 2021 RAPT Therapeutics Reports First Quarter 2021 Financial Results Read More »
Revolution Medicines Reports First Quarter Financial Results and Update on Corporate Progress Portfolio News / By Karina Tin May 10, 2021 Revolution Medicines Reports First Quarter Financial Results and Update on Corporate Progress Read More »
Constellation Pharmaceuticals Announces First-Quarter 2021 Financial Results and Provides Business Update Portfolio News / By Karina Tin May 10, 2021 Constellation Pharmaceuticals Announces First-Quarter 2021 Financial Results and Provides Business Update Read More »
NGM Bio Provides Business Highlights and Reports First Quarter 2021 Financial Results Portfolio News / By Karina Tin May 6, 2021 NGM Bio Provides Business Highlights and Reports First Quarter 2021 Financial Results Read More »
ORIC Pharmaceuticals Reports First Quarter 2021 Financial Results and Operational Update Portfolio News / By Karina Tin May 6, 2021 ORIC Pharmaceuticals Reports First Quarter 2021 Financial Results and Operational Update Read More »
‘Changing the whole game of drug discovery’: Legendary R&D vet Roger Perlmutter leaps back into work as a biotech CEO Portfolio News / By Karina Tin May 5, 2021 ‘Changing the whole game of drug discovery’: Legendary R&D vet Roger Perlmutter leaps back into work as a biotech CEO Read More »
Eikon Therapeutics Closes $148 Million Series A Financing to Develop High-Throughput, Super-Resolution Microscopy for Drug Discovery Portfolio News / By Karina Tin May 5, 2021 Eikon Therapeutics Closes $148 Million Series A Financing to Develop High-Throughput, Super-Resolution Microscopy for Drug Discovery Read More »
